PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.94%
Revenue growth above 1.5x AVGO's 5.15%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.15%
Gross profit growth above 1.5x AVGO's 7.72%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
24.95%
EBIT growth above 1.5x AVGO's 9.20%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
24.95%
Operating income growth above 1.5x AVGO's 9.20%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
24.16%
Net income growth above 1.5x AVGO's 4.77%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
23.38%
EPS growth above 1.5x AVGO's 8.62%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
23.68%
Diluted EPS growth above 1.5x AVGO's 8.93%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.36%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.16%
Slight or no buyback while AVGO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.65%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
43.12%
OCF growth above 1.5x AVGO's 21.72%. David Dodd would confirm a clear edge in underlying cash generation.
58.57%
FCF growth above 1.5x AVGO's 22.84%. David Dodd would verify if the firm’s strategic investments yield superior returns.
517.62%
10Y revenue/share CAGR at 50-75% of AVGO's 737.75%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
290.42%
5Y revenue/share CAGR above 1.5x AVGO's 90.54%. David Dodd would look for consistent product or market expansions fueling outperformance.
102.92%
3Y revenue/share CAGR above 1.5x AVGO's 42.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
3054.94%
10Y OCF/share CAGR above 1.5x AVGO's 1099.59%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1148.88%
5Y OCF/share CAGR above 1.5x AVGO's 164.09%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
186.10%
3Y OCF/share CAGR above 1.5x AVGO's 54.42%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1411.18%
Net income/share CAGR 1.25-1.5x AVGO's 1053.02%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
703.97%
5Y net income/share CAGR 1.25-1.5x AVGO's 479.97%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
110.00%
Below 50% of AVGO's 263.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
453.02%
10Y equity/share CAGR in line with AVGO's 477.82%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
304.44%
5Y equity/share CAGR above 1.5x AVGO's 6.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
134.17%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
38.19%
Below 50% of AVGO's 294.56%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
7.02%
Below 50% of AVGO's 60.70%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
18.58%
AR growth well above AVGO's 21.43%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
Inventory growth well above AVGO's 9.74%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.50%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
12.23%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
63.60%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
7.98%
R&D growth drastically higher vs. AVGO's 4.56%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.15%
SG&A declining or stable vs. AVGO's 14.64%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.